Luminelle
Private Company
Total funding raised: $12M
Overview
Luminelle (UVision360) is a private, commercial-stage medical device company targeting the significant market opportunity in office-based gynecological procedures. Its flagship product, the FDA 510(k)-cleared Luminelle DTx Hysteroscopy System, is designed to address unmet needs by providing a high-definition, cost-effective alternative to traditional endoscopic towers, potentially saving up to 75% in costs. The company aims to capitalize on the trend of moving minimally invasive diagnostic and therapeutic procedures out of the operating room and into the clinician's office, improving access and convenience for patients with conditions like abnormal uterine bleeding.
Technology Platform
Integrated office-based hysteroscopy system featuring a dual-line flexible hysteroscope with high-definition optics, designed for cost-effective and convenient diagnostic and therapeutic uterine procedures.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competition primarily comes from traditional endoscopic tower systems from large medtech companies (e.g., Karl Storz, Olympus, Hologic) used in hospital ORs and ASCs. Other competitors may include older, less sophisticated office hysteroscopy systems. Luminelle's differentiation is its fully integrated, modern design offering OR-level image quality at a substantially lower cost point specifically for the office environment.